Hacking Cancer Together

We dream big. We imagine a world where cancer is curable.

What’s New at the Parker Institute

CD40 Pancreatic Cancer Trial Graphic Press Release

The Parker Institute for Cancer Immunotherapy and the Cancer Research Institute Announce First Patients Treated in Pancreatic Cancer Clinical Trial Combining Immunotherapy and Chemotherapy

September 20, 2017

UCLA Antoni Ribas Lab

Research Updates

UCLA Study Shows Virus Plus Immunotherapy Hold Promise for Advanced Melanoma

September 7, 2017

Emily_at_PICI_WHATSNEW_body

Patient Stories

From leukemia to cancer-free: how CAR-T immunotherapy saved Emily Whitehead

August 30, 2017

The Parker Institute for Cancer Immunotherapy enables real collaboration, accelerating ambitious research to deliver new immunotherapies engineered to save lives.

World-renowned experts from leading cancer centers are at the forefront of our research.

Our model allows us to work with top talent across disciplines beyond our six centers.

About Our Model

Open in Twitter

Parker Institute

Parker Institute @parkerici RT @EricTopol: Is CAR-T cell therapy like a Model T car? https://t.co/sc3AzOc7AK @CellCellPress @CellPressNews Well done by @HelenaXiaoho… 4 hours ago

Open in Twitter

Parker Institute

Parker Institute @parkerici RT @UCSFCancer: Krummel @UCSF @parkerici & Kurzrock @UCSD on promise and challenges in #cancer #immunotherapy https://t.co/gBzyg7ZTUT via… 4 hours ago

Open in Twitter

Parker Institute

Parker Institute @parkerici RT @sparker: The power of collaboration: https://t.co/8R5fUacy6w https://t.co/lMkk2xNVoo 1 day ago

Follow @parkerici